Science Market Update

Michigan Researchers: Over $2 Billion in R&D

Posted by Andrea Inks on Thu, Feb 07, 2019


Read More

Tags: University of Michigan research, Michigan State, Research Event, Zombie cells, U of M retirement study, Trade show

UCLA Researchers Design a Renewable Source of Cancer Fighting T Cells

Posted by Andrea Inks on Mon, Jan 28, 2019

Read More

Tags: UCLA research funding, UCLA, Ucla Research Vendors, UCLA stem cells, life science research at UCLA

15.4M in NIH Grants at UPENN’s ACC

Posted by Andrea Inks on Tue, Jan 08, 2019

With $15.4M NIH grant, the ACC will continue to innovate to reduce the burden of cancer

Read More

Tags: UPenn, Cancer Science, NIH grant, NIH funding

UGA receives  $10M Grant to Create Computational And Informatics Tools for Glycoscience

Posted by Andrea Inks on Thu, Jan 03, 2019

The $10M grant, which was given jointly to The University of Georgia, Athens and George Washington University, will be used to build a glycoscience informatics portal, called GlyGen. This portal is essential for glycoscience to advance. GlyGen will also incorporate glycan data with gene and protein data, to allow for greater analysis.

Read More

Tags: UGA, Glycoscience, NIH grant, University of Georgia Athens, GlyGen

Utah’s Department of Bioengineering Spends $17M Annually on Research and Produces Breakthrough in 3D Bioprinting

Posted by Rebecca Inch-Partridge on Fri, Dec 28, 2018

The University of Utah is recognized as a Top-Tier 1 research university by the Carnegie Classification of Institutions in Higher Education. According to the Vice President of Research the University was awarded 2,326 grants in 2018 and had $515 million in research funding. According to the National Institutes of Health, the university received $152,843,112 from them this year.

Read More

Tags: Univ of Utah, University of Utah Salt Lake City, Utah, university research funding, 3D Printing and Medical Devices, 3D bioprinting, BioResearch Product Faire™

University of Kansas Uses $25M NIH Grant to fund Multiple Research Projects

Posted by Gloria Beverage on Thu, Dec 20, 2018

Thanks to a five-year, $25 million grant, the largest given to the University of Kansas by the National Institutes of Health (NIH), several campus research projects have been funded to promote research development in high priority areas.

Read More

Tags: Midwest, Research Funding, Kansas, University of Kansas, Leukemia

Washington U. St. Louis Receives $20M Gift & $14.5M in Grant Funding

Posted by Gloria Beverage on Thu, Dec 13, 2018


Read More

Tags: Washington University, Washington University St. Louis, WUSTL, Biotechnology vendor show, Bioresearch funding, BioResearch Product Faire, Translational Science, Pediatric Neurology, Birth Defects

NIH awards $11.5 Million Grant to The University of Utah

Posted by Andrea Inks on Tue, Dec 11, 2018

The NIH awarded $11.5 million grant to The University of Utah to Study Sarcomagenesis.

Read More

Tags: Univ of Utah, University of Utah Salt Lake City, cancer research, sarcomagenesis, Utah, Jones Lab

New Research Facility Opens at USC Keck School

Posted by Gloria Beverage on Thu, Dec 06, 2018

USC recently opened the USC Stevens Hall for Neuroimaging, the new home for the Mark and Mary Stevens Neuroimaging and Informatics Institute. The sleek, modern, state-of-the-art research building is located on the southern edge of USC's Health Sciences Campus and will help accelerate research on neurological disorders such as autism and Alzheimer’s Disease.

Read More

Tags: University of Southern California, USC, New research center, New research facilities, new research building, California, CA, Southwest Region, Neurological Research, Neuroradiology

Duke: Researchers find how Natural Killer Cells Regulate Protective HIV Antibodies

Posted by Andrea Inks on Tue, Dec 04, 2018

Duke received a $28 Million grant from the NIH to discover immunologic research directed at tackling major scientific problems that hinder the development of an effective HIV-1 vaccine. The vaccine strategy will be based on identifying and targeting novel HIV-1 vulnerabilities to B, T and NK cell immune responses and then using this information to design vaccines that will induce protective immunity at the time and location of HIV-1 transmission.

Read More

Tags: HIV research, HIV Vaccine, duke medicine, Duke University

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News